S&P 500   5,070.88 (+0.03%)
DOW   38,945.04 (-0.32%)
QQQ   437.75 (+0.27%)
AAPL   181.12 (-0.02%)
MSFT   407.05 (-0.12%)
META   484.94 (+0.66%)
GOOGL   138.32 (+0.55%)
AMZN   174.30 (-0.25%)
TSLA   202.54 (+1.57%)
NVDA   788.25 (-0.34%)
NIO   5.78 (+2.30%)
AMD   177.60 (+0.90%)
BABA   77.72 (+1.58%)
T   16.63 (+0.18%)
F   12.00 (+0.42%)
MU   90.71 (+1.40%)
CGC   3.55 (+2.31%)
GE   153.85 (-0.59%)
DIS   108.24 (+0.52%)
AMC   4.64 (+4.27%)
PFE   26.99 (-0.70%)
PYPL   59.62 (+0.49%)
XOM   104.14 (-0.11%)
S&P 500   5,070.88 (+0.03%)
DOW   38,945.04 (-0.32%)
QQQ   437.75 (+0.27%)
AAPL   181.12 (-0.02%)
MSFT   407.05 (-0.12%)
META   484.94 (+0.66%)
GOOGL   138.32 (+0.55%)
AMZN   174.30 (-0.25%)
TSLA   202.54 (+1.57%)
NVDA   788.25 (-0.34%)
NIO   5.78 (+2.30%)
AMD   177.60 (+0.90%)
BABA   77.72 (+1.58%)
T   16.63 (+0.18%)
F   12.00 (+0.42%)
MU   90.71 (+1.40%)
CGC   3.55 (+2.31%)
GE   153.85 (-0.59%)
DIS   108.24 (+0.52%)
AMC   4.64 (+4.27%)
PFE   26.99 (-0.70%)
PYPL   59.62 (+0.49%)
XOM   104.14 (-0.11%)
S&P 500   5,070.88 (+0.03%)
DOW   38,945.04 (-0.32%)
QQQ   437.75 (+0.27%)
AAPL   181.12 (-0.02%)
MSFT   407.05 (-0.12%)
META   484.94 (+0.66%)
GOOGL   138.32 (+0.55%)
AMZN   174.30 (-0.25%)
TSLA   202.54 (+1.57%)
NVDA   788.25 (-0.34%)
NIO   5.78 (+2.30%)
AMD   177.60 (+0.90%)
BABA   77.72 (+1.58%)
T   16.63 (+0.18%)
F   12.00 (+0.42%)
MU   90.71 (+1.40%)
CGC   3.55 (+2.31%)
GE   153.85 (-0.59%)
DIS   108.24 (+0.52%)
AMC   4.64 (+4.27%)
PFE   26.99 (-0.70%)
PYPL   59.62 (+0.49%)
XOM   104.14 (-0.11%)
S&P 500   5,070.88 (+0.03%)
DOW   38,945.04 (-0.32%)
QQQ   437.75 (+0.27%)
AAPL   181.12 (-0.02%)
MSFT   407.05 (-0.12%)
META   484.94 (+0.66%)
GOOGL   138.32 (+0.55%)
AMZN   174.30 (-0.25%)
TSLA   202.54 (+1.57%)
NVDA   788.25 (-0.34%)
NIO   5.78 (+2.30%)
AMD   177.60 (+0.90%)
BABA   77.72 (+1.58%)
T   16.63 (+0.18%)
F   12.00 (+0.42%)
MU   90.71 (+1.40%)
CGC   3.55 (+2.31%)
GE   153.85 (-0.59%)
DIS   108.24 (+0.52%)
AMC   4.64 (+4.27%)
PFE   26.99 (-0.70%)
PYPL   59.62 (+0.49%)
XOM   104.14 (-0.11%)

BioVie (BIVI) Earnings Date, Estimates & Call Transcripts

$1.22
-0.01 (-0.81%)
(As of 10:54 AM ET)
Skip Charts & View Estimated and Actual Earnings Data

BIVI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BIVI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BioVie Analyst EPS Estimates

Current Year EPS Consensus Estimate:($1.14) EPS
Next Year EPS Consensus Estimate: ($1.30) EPS

BIVI Earnings Date and Information

BioVie has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 10th, 2024 based off prior year's report dates.

BioVie Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/10/2024
Estimated)
------- 
11/8/2023Q1 2024-($0.29)($0.29)($0.29)--
8/16/2023Q4 2023($0.37)($0.23)+$0.14($0.23)--
5/12/2023Q3 2023($0.31)($0.43)($0.12)($0.43)--
2/10/2023Q2 2023-($0.50)($0.50)($0.50)--
11/4/2022Q1 2023-($0.38)($0.38)($0.38)--
9/27/2022Q4 2022-($0.33)($0.33)($0.33)--
5/11/2022Q3 2022($0.52)($0.28)+$0.24($0.28)--
2/8/2022Q2 2022($0.41)($0.22)+$0.19($0.22)--
11/10/2021Q1 2022-($0.23)($0.23)($0.23)--
8/30/2021Q4 2021-($10.18)($10.18)($10.18)--












BioVie Earnings - Frequently Asked Questions

When is BioVie's earnings date?

BioVie has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 10th, 2024 based off last year's report dates. Learn more on BIVI's earnings history.

How much profit does BioVie generate each year?

BioVie (NASDAQ:BIVI) has a recorded net income of -$50.26 million. BIVI has generated -$1.17 earnings per share over the last four quarters.

What is BioVie's EPS forecast for next year?

BioVie's earnings are expected to decrease from ($1.14) per share to ($1.30) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:BIVI) was last updated on 2/27/2024 by MarketBeat.com Staff